EGFR and nasopharyngeal carcinoma: Our lab previously reported that NK cells from NPC patients can induce ADCC of C666-1 NPC cells in the presence of cetuximab, a monoclonal antibody against epidermal growth factor receptor (EGFR) [128,129].